The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers

Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells

(2016) Jia Guo et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy

(2011) Amit K. Tiwari et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Pharmacokinetics and Tissue Distribution of Dual-Targeting Daunorubicin Liposomes in Mice

(2011) Xue Ying et al.   PHARMACOLOGY

Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats

(2010) Wawaimuli Arozal et al.   TOXICOLOGY

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

(2009) C Hegedűs et al.   BRITISH JOURNAL OF PHARMACOLOGY

Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment

(2009) Yasuyuki Sadzuka et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Dual-Targeting Topotecan Liposomes Modified with Tamoxifen and Wheat Germ Agglutinin Significantly Improve Drug Transport across the Blood−Brain Barrier and Survival of Brain Tumor-Bearing Animals

(2009) Ju Du et al.   MOLECULAR PHARMACEUTICS